Security key
19249H103
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)
CUSIP: 19249H103
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 153,624,096
- Total 13F shares
- 46,927,893
- Share change
- +6,781,648
- Total reported value
- $626,702,945
- Put/Call ratio
- 79%
- Price per share
- $13.35
- Number of holders
- 90
- Value change
- +$87,202,617
- Number of buys
- 48
- Number of sells
- 45
Report period
Q3 2017
Institutions
90
Top holders
10
CHRS full security history
Newer quarter: Q4 2017
Previous quarter: Q2 2017
Coherus Oncology, Inc. SEC filings
Coherus Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19249H103
Recent filing periods:
Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
5%
|
7,693,124
|
$110,396,000 | — | 30 Jun 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
4,898,135
|
$70,288,000 | — | 30 Jun 2017 | |
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
2%
|
3,055,055
|
$43,840,000 | — | 30 Jun 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
2,951,581
|
$42,355,000 | — | 30 Jun 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
2,255,467
|
$32,367,000 | — | 30 Jun 2017 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.2%
|
1,802,611
|
$25,867,000 | — | 30 Jun 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.92%
|
1,416,572
|
$20,329,000 | — | 30 Jun 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.91%
|
1,391,711
|
$19,971,000 | — | 30 Jun 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.91%
|
1,391,216
|
$19,963,950 | — | 30 Jun 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.7%
|
1,079,700
|
$15,494,000 | — | 30 Jun 2017 | |
| Carlson Capital, L.P. |
13F
|
Company |
0.66%
|
1,018,483
|
$14,615,000 | — | 30 Jun 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.65%
|
1,001,104
|
$14,366,000 | — | 30 Jun 2017 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.45%
|
693,900
|
$9,957,000 | — | 30 Jun 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.44%
|
683,452
|
$9,808,000 | — | 30 Jun 2017 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.4%
|
620,300
|
$8,901,000 | — | 30 Jun 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.38%
|
586,027
|
$8,409,000 | — | 30 Jun 2017 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.37%
|
562,810
|
$8,076,000 | — | 30 Jun 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
464,056
|
$6,660,000 | — | 30 Jun 2017 | |
| AXA S.A. |
13F
|
Company |
0.27%
|
413,728
|
$5,937,000 | — | 30 Jun 2017 | |
| HIGHLAND CAPITAL MANAGEMENT LP |
13F
|
Company |
0.25%
|
378,230
|
$5,428,000 | — | 30 Jun 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
373,725
|
$5,362,000 | — | 30 Jun 2017 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.22%
|
338,000
|
$4,850,000 | — | 30 Jun 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
323,126
|
$4,636,000 | — | 30 Jun 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.2%
|
310,923
|
$4,462,000 | — | 30 Jun 2017 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.16%
|
241,505
|
$3,466,000 | — | 30 Jun 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
233,066
|
$3,344,000 | — | 30 Jun 2017 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.15%
|
225,592
|
$3,238,000 | — | 30 Jun 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.13%
|
193,000
|
$2,770,000 | — | 30 Jun 2017 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.12%
|
189,933
|
$2,726,000 | — | 30 Jun 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
169,839
|
$2,437,000 | — | 30 Jun 2017 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.11%
|
168,872
|
$2,423,000 | — | 30 Jun 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
161,366
|
$2,316,000 | — | 30 Jun 2017 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.1%
|
158,777
|
$2,278,000 | — | 30 Jun 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.1%
|
149,728
|
$2,148,000 | — | 30 Jun 2017 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
145,000
|
$2,081,000 | — | 30 Jun 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
140,923
|
$2,022,000 | — | 30 Jun 2017 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.09%
|
140,390
|
$2,015,000 | — | 30 Jun 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
119,300
|
$1,711,000 | — | 30 Jun 2017 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
99,950
|
$1,434,000 | — | 30 Jun 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.06%
|
93,550
|
$1,343,000 | — | 30 Jun 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.06%
|
90,000
|
$1,292,000 | — | 30 Jun 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.06%
|
84,611
|
$1,214,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
81,613
|
$1,170,000 | — | 30 Jun 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
67,940
|
$975,000 | — | 30 Jun 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
65,267
|
$937,000 | — | 30 Jun 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
63,570
|
$912,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
60,868
|
$874,000 | — | 30 Jun 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
60,247
|
$865,000 | — | 30 Jun 2017 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.04%
|
57,140
|
$820,000 | — | 30 Jun 2017 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.04%
|
55,000
|
$789,000 | — | 30 Jun 2017 |
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2017
As of 30 Sep 2017,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,927,893 shares.
The largest 10 holders included
FMR LLC, Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Kohlberg Kravis Roberts & Co. L.P., VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, UBS ASSET MANAGEMENT AMERICAS INC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
90
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
105
Q3 2017 holders
90
Holder diff
-15
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.